293 results on '"Lonn E"'
Search Results
2. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial
3. Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial
4. Vitamin D and progression of carotid intima‐media thickness in HIV‐positive Canadians
5. Low resting heart rates are associated with new-onset atrial fibrillation in patients with vascular disease: results of the ONTARGET/TRANSCEND studies
6. Common carotid intima-media thickness does not add to Framingham risk score in individuals with diabetes mellitus: the USE-IMT initiative
7. IMPLEMENTATION OF A SPECIALIZED HEART FUNCTION INPATIENT UNIT TO OPTIMIZE PATIENT CARE AND STAFF/LEARNER SATISFACTION
8. Poster session Thursday 12 December - PM: 12/12/2013, 14: 00–18: 00Location: Poster area
9. A comparison of the assessment and management of cardiometabolic risk in patients with and without type 2 diabetes mellitus in Canadian primary care
10. The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis
11. Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)
12. Increased cardiovascular risk after pre-eclampsia in women with dysglycaemia
13. Myocardial infarction Associated with Recency of Immigration to Ontario
14. Automated oscillometric blood pressure versus auscultatory blood pressure as a predictor of carotid intima–medial thickness in male firefighters
15. Venous thromboembolism in association with features of the metabolic syndrome
16. Automated oscillometric blood pressure versus auscultatory blood pressure as a predictor of carotid intima-medial thickness in male firefighters
17. The HOPE (Heart Outcomes Prevention Evaluation) Study and its Consequences
18. In-Hospital Initiation of Sacubitril/Valsartan in Stabilised Patients with Heart Failure and Reduced Ejection Fraction Naïve to Renin-Angiotensin System Blocker: An Analysis of the Transition Study
19. Initiation of Sacubitril/Valsartan in Patients with De Novo Heart Failure with Reduced Ejection Fraction: An Analysis of the Transition Study
20. THE HIGH PREVALENCE OF FAMILIAL HYPERCHOLESTEROLEMIA IN A POPULATION OF ASCVD PATIENTS WITH LDL-C ABOVE TARGET: AN ANALYSIS FROM THE REACT REGISTRY
21. Low resting heart rates are associated with new-onset atrial fibrillation in patients with vascular disease: results of the ONTARGET/ TRANSCEND studies.
22. Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies.
23. The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data.
24. The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions.
25. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.
26. Risk of premature stroke in recent immigrants (PRESARIO): Population-based matched cohort study.
27. Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial.
28. Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.
29. Cardiac Function Stratification Based on Echocardiographic or Clinical Markers of Left Ventricular Filling Pressures Predicts Death and Hospitalization Better Than Stratification by Ventricular Systolic Function Alone.
30. Randomized clinical trial of homocysteine level lowering therapy and fractures.
31. Homocysteine in the prevention of ischemic heart disease, stroke and venous thromboembolism: therapeutic target or just another distraction?
32. Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial.
33. Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES.
34. Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
35. Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.
36. Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE Study.
37. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease.
38. Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study.
39. Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
40. Use of ramipril in preventing stroke: double blind randomised trial.
41. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril.
42. Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study.
43. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).
44. 1.10: A pilot study evaluating the predictive value of noninvasive pharmacological cardiovascular stress testing before orthopaedic surgery
45. We-W31:5 Homocysteine and folic acid levels and relation to carotid atherosclerosis in high-risk individuals
46. Mo-P4:279 Prevalence and predictors of subclinical atherosclerosis among asymptomatic low risk individuals in a multiethnic population
47. Carotid artery intima-media thickness--a new noninvasive gold standard for assessing the anatomic extent of atherosclerosis and cardiovascular risk?
48. PCV4 FIRST ANALYSIS OF CLINICAL SIGNIFICANT INTERACTIONS IN HIGH-RISK CARDIOVSCULAR PATIENTS ENROLLED INTO HOPE-TOO TRIAL IN SLOVAKIA IN THE THIRD YEAR OF TRIAL PARTICIPATION
49. Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: A substudy of the Heart Outcomes Prevention Evaluation (HOPE) trial
50. Dose response of ACE inhibitors: implications of the SECURE trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.